Scientific Advisory Board

Mitchell Kronenberg, Ph.D.

President and Scientific Director
LIAI - La Jolla Institute for Allergy & Immunology

Mitchell Kronenberg was appointed President of the La Jolla Institute for Allergy and Immunology in September 2003. He is responsible for the overall administration of physical resources, finances and space at the Institute; and works with the Institute’s board of directors, faculty, and executive management to develop and implement strategic plans for shaping the Institute’s future. In addition to his duties as LIAI’s chief executive officer, Dr. Kronenberg serves as Scientific Director of the Institute and Head of the Division of Developmental Immunology. He conducts an active research program on the development of the immune system and the pathogenesis of autoimmune disease, and is a world-renowned expert in the fields of mucosal and innate immunity.

Dr. Kronenberg graduated with a bachelor’s degree in biochemistry from Columbia University, and earned his Ph.D. from the California Institute of Technology (Caltech) in 1983. He stayed on at Caltech as a postdoctoral fellow, and joined the faculty of the UCLA School of Medicine in 1986, serving first as Assistant, and later as Associate and full Professor. In 1997, he moved to LIAI to head the Division of Developmental Immunology. He also is an Adjunct Professor of Biology at the University of California, San Diego.

Dr. Kronenberg is the co-author of more than 215 scientific publications and holds six research grants from the U.S. National Institutes of Health (NIH). He has served on a number of grant review panels for NIH and other private medical research agencies, and is on the editorial board of four scientific journals. He is the winner of the Richard Dwyer award for cancer research (UCLA) and has been the Kroc Professor of Medicine at the University of California, Davis, and the Wellcome Foundation visiting Professor at Harvard University.